Search

Gabriele M Zybarth

from Westport, MA
Age ~61
Get Report
Also known as:
Gabrielle Zybarth, Gabrielle M Zabarth
Phone and address:
1500 Drift Rd, Horseneck Beach, MA 02790
(508) 636-4207
Related to:
Barbara Zybarth
Connected to:
Emery N Zyber, 70Jocelyn M Zybert, 38Jack A Zybura, 37Rosemarie C Zyburo, 42Adam Zych, 36Brittany M Zych, 35Danielle Zych, 43Elizabeth A Zych, 45Eva B Zych, 63Gretchen L Zych, 49

Gabriele Zybarth Phones & Addresses

  • 1500 Drift Rd, Westport, MA 02790 (508) 636-4207
  • 6 Steeple View Rd, Little Compton, RI 02837 (401) 635-8331
  • 171 Old Mountain Rd, West Kingston, RI 02892 (401) 539-8434
  • East Setauket, NY
  • Oyster Bay, NY

Work

Position: Professional/Technical

Public records

Vehicle Records

Gabriele Zybarth

View page
Address:
1500 Drift Rd, Westport, MA 02790
Phone:
(508) 636-4207
VIN:
WBXPC93437WE78144
Make:
BMW
Model:
X3
Year:
2007

Publications

Us Patents

Generation Of Type I/Type Ii Hybrid Form Of Bovine Viral Diarrhea Virus For Use As Vaccine

View page
US Patent:
20030104612, Jun 5, 2003
Filed:
Aug 27, 2002
Appl. No.:
10/228406
Inventors:
Xuemei Cao - East Lyme CT, US
Gabriele Zybarth - Little Compton RI, US
Assignee:
Pfizer Inc.
International Classification:
C07H021/04
C12P019/34
A61K039/12
C12N007/00
C12N007/01
C12N015/00
C12N015/09
C12N015/63
C12N015/70
C12N015/74
US Classification:
435/320100, 435/235100, 435/091100, 424/199100, 424/204100, 424/205100, 536/023720
Abstract:
The present invention provides genetically engineered type I/type II hybrid BVDV viruses. The hybrid viruses, as well as the hybrid viral genome, can be used in immunogenic compositions and vaccines for protecting cattle from BVDV infection.

Attenuated Forms Of Bovine Viral Diarrhea Virus

View page
US Patent:
20040146854, Jul 29, 2004
Filed:
Nov 21, 2001
Appl. No.:
09/989933
Inventors:
Xuemei Cao - East Lyme CT, US
Gabriele Zybarth - West Kingston RI, US
Assignee:
Pfizer Inc.
International Classification:
C12Q001/70
C07H021/04
C12N007/01
C12N015/86
US Classification:
435/005000, 435/069300, 435/235100, 435/456000, 435/325000, 536/023720
Abstract:
The present invention relates to attenuated forms of bovine viral diarrhea (BVD) viruses. In particular, the present invention relates to attenuated BVD viruses made by mutating the Nprotease gene and inserting a bovine ubiquitin coding sequence. The attenuated viruses of the present invention can be used to raise antibodies against BVDV. Immunogenic compositions and vaccine compositions, as well as therapeutic and diagnosis methods, are also provided by the present invention.

Marked Bovine Viral Diarrhea Virus Vaccines

View page
US Patent:
20080305130, Dec 11, 2008
Filed:
Nov 24, 2006
Appl. No.:
11/995779
Inventors:
Chichi Huang - Berwyn PA, US
Michael G. Sheppard - Victoria, AU
Xuemei Cao - Scituate MA, US
Gabriele M. Zybarth - Westport MA, US
International Classification:
A61K 39/12
C12N 7/00
C12Q 1/70
US Classification:
4242181, 4352351, 435 5
Abstract:
The present invention is directed to a bovine viral diarrhea virus comprising at least one helicase domain amino acid mutation wherein the mutation in the NS3 domain results in a loss of recognition by a monoclonal antibody raised against wild-type NS3 but wherein viral RNA replication and the generation of infectious virus is retained. The present invention is useful, for example, to produce a marked bovine viral diarrhea virus vaccine or to differentiate between vaccinated and infected or unvaccinated animals.

Marked Bovine Viral Diarrhea Virus Vaccines

View page
US Patent:
20120021001, Jan 26, 2012
Filed:
Jun 22, 2011
Appl. No.:
13/165877
Inventors:
Chichi Huang - Berwyn PA, US
Michael G. Sheppard - Victoria, AU
Xuemei Cao - Scituate MA, US
Gabriele M. Zybarth - Westport MA, US
Assignee:
PFIZER INC. - New York NY
International Classification:
A61K 39/12
C12Q 1/70
C12N 7/00
US Classification:
4242181, 4352351, 435 5
Abstract:
The present invention is directed to a bovine viral diarrhea virus comprising at least one helicase domain amino acid mutation wherein the mutation in the NS3 domain results in a loss of recognition by a monoclonal antibody raised against wild-type NS3 but wherein viral RNA replication and the generation of infectious virus is retained. The present invention is useful, for example, to produce a marked bovine viral diarrhea virus vaccine or to differentiate between vaccinated and infected or unvaccinated animals.
Control profile
Gabriele M Zybarth from Westport, MA, age ~61 Get Report